Peripheral Nerve Stimulators Market (2026 - 2033)

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                            1.1.1. Type
                            1.1.2. Indication
                            1.1.3. Mechanism
                            1.1.4. End-User
                            1.1.5. Country scope
                            1.1.6. Estimates and forecast timeline
                    1.2. Research Methodology
                    1.3. Information Procurement
                            1.3.1. Purchased database
                            1.3.2. GVR’s internal database
                            1.3.3. Secondary sources
                            1.3.4. Primary research
                            1.3.5. Details of primary research
                    1.4. Information or Data Analysis
                            1.4.1. Data analysis models
                    1.5. Market Formulation & Validation
                    1.6. Model Details
                            1.6.1. Commodity flow analysis (Model 1)
                                    1.6.1.1. Approach 1: Commodity flow approach
                            1.6.2. Volume price analysis (Model 2)
                                    1.6.2.1. Approach 2: Volume price analysis
                    1.7. List of Secondary Sources
                    1.8. List of Primary Sources
                    1.9. Objectives
                            1.9.1. Objective 1
                            1.9.2. Objective 2

Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                    2.3. Competitive Insights

Chapter 3. Peripheral Nerve Stimulators Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                            3.1.1. Parent market outlook
                    3.2. Market Dynamics
                            3.2.1. Market driver analysis
                                    3.2.1.1. Rising prevalence of chronic pain disorders
                                    3.2.1.2. Growing preference for minimally invasive therapies
                                    3.2.1.3. Opioid crisis and shift toward non-opioid pain management
                                    3.2.1.4. Expanding applications beyond chronic pain
                            3.2.2. Market restraint analysis
                                    3.2.2.1. High cost of devices and procedures
                                    3.2.2.2. Risk of complications and device-related issues
                            3.2.3. Market opportunity analysis
                                    3.2.3.1. Expansion into new indications
                                    3.2.3.2. Adoption in outpatient & home-care settings
                                    3.2.3.3. Rising demand for personalized pain management
                                    3.2.3.4. Integration of Wireless and Wearable Technologies
                            3.2.4. Market challenge analysis
                                    3.2.4.1. Competition from alternative therapies
                                    3.2.4.2. Patient selection challenges
                    3.3. Peripheral Nerve Stimulators Market Analysis Tools
                            3.3.1. Industry Analysis - Porter’s
                                    3.3.1.1. Bargaining power of suppliers
                                    3.3.1.2. Bargaining power of buyers
                                    3.3.1.3. Threat of substitutes
                                    3.3.1.4. Threat of new entrants
                                    3.3.1.5. Competitive rivalry
                            3.3.2. PESTEL Analysis
                                    3.3.2.1. Political & Legal Landscape
                                    3.3.2.2. Economic and Social Landscape
                                    3.3.2.3. Technological landscape

Chapter 4. Peripheral Nerve Stimulators Market: Type Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. Peripheral Nerve Stimulators Market Type Movement Analysis
                    4.3. Peripheral Nerve Stimulators Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
                    4.4. Temporary Percutaneous Systems
                            4.4.1. Temporary percutaneous systems market estimates and forecasts for 2021 to 2033 (USD Million)
                    4.5. Wireless Micro-Implantable Systems
                            4.5.1. Wireless micro-implantable systems market estimates and forecasts for 2021 to 2033, (USD Million)
                    4.6. Traditional IPG Systems
                            4.6.1. Traditional IPG systems market estimates and forecasts for 2021 to 2033, (USD Million)

Chapter 5. Peripheral Nerve Stimulators Market: Indication Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. Peripheral Nerve Stimulators Market Indication Movement Analysis
                    5.3. Peripheral Nerve Stimulators Market Size & Trend Analysis, by Indication, 2021 to 2033 (USD Million)
                    5.4. Restorative Multifidus Stimulation
                            5.4.1. Restorative multifidus stimulation market estimates and forecasts for 2021 to 2033, (USD Million)
                    5.5. Peripheral Neuropathic & Post-Surgical/Traumatic Pain
                            5.5.1. Peripheral neuropathic & post-surgical/traumatic pain market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 6. Peripheral Nerve Stimulators Market: Mechanism Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. Peripheral Nerve Stimulators MarketPeripheral Nerve Stimulators Market Mechanism Movement Analysis
                    6.3. Peripheral Nerve Stimulators MarketPeripheral Nerve Stimulators Market Size & Trend Analysis, by Mechanism, 2021 to 2033 (USD Million)
                    6.4. External Direct Power
                            6.4.1. External direct power market estimates and forecasts for 2021 to 2033, (USD Million)
                    6.5. Transcutaneous Wireless Power
                            6.5.1. Transcutaneous wireless power market estimates and forecasts for 2021 to 2033, (USD Million)
                    6.6. Internal Battery Power
                            6.6.1. Internal battery power market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 7. Peripheral Nerve Stimulators Market: End-User Estimates & Trend Analysis
                    7.1. Segment Dashboard
                    7.2. Peripheral Nerve Stimulators Market End-User Movement Analysis
                    7.3. Peripheral Nerve Stimulators Market Size & Trend Analysis, by End-User, 2021 to 2033 (USD Million)
                    7.4. Hospital Outpatient Departments
                            7.4.1. Hospital outpatient departments market estimates and forecasts for 2021 to 2033, (USD Million)
                    7.5. Ambulatory Surgical Centers
                            7.5.1. Ambulatory surgical centers market estimates and forecasts for 2021 to 2033 (USD Million)
                    7.6. Outpatient Interventional Pain Clinics / OBLs
                            7.6.1. Outpatient interventional pain clinics / OBLs market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 8. Peripheral Nerve Stimulators Market: Country Estimates & Trend Analysis
                    8.1. Country Dashboard
                    8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
                    8.3. U.S.
                            8.3.1. Key country dynamics
                            8.3.2. Competitive scenario
                            8.3.3. Regulatory framework
                            8.3.4. Reimbursement scenario
                            8.3.5. U.S. market estimates and forecasts, 2021 - 2033
                    8.4. Canada
                            8.4.1. Key country dynamics
                            8.4.2. Competitive scenario
                            8.4.3. Regulatory framework
                            8.4.4. Reimbursement scenario
                            8.4.5. Canada market estimates and forecasts, 2021 - 2033
                    8.5. Germany
                            8.5.1. Key country dynamics
                            8.5.2. Competitive scenario
                            8.5.3. Regulatory framework
                            8.5.4. Reimbursement scenario
                            8.5.5. Germany market estimates and forecasts, 2021 - 2033
                    8.6. UK
                            8.6.1. Key country dynamics
                            8.6.2. Competitive scenario
                            8.6.3. Regulatory framework
                            8.6.4. Reimbursement scenario
                            8.6.5. UK market estimates and forecasts, 2021 - 2033
                    8.7. Italy
                            8.7.1. Key country dynamics
                            8.7.2. Competitive scenario
                            8.7.3. Regulatory framework
                            8.7.4. Reimbursement scenario
                            8.7.5. Italy market estimates and forecasts, 2021 - 2033
                    8.8. Spain
                            8.8.1. Key country dynamics
                            8.8.2. Competitive scenario
                            8.8.3. Regulatory framework
                            8.8.4. Reimbursement scenario
                            8.8.5. Spain market estimates and forecasts, 2021 - 2033
                    8.9. Denmark
                            8.9.1. Key country dynamics
                            8.9.2. Competitive scenario
                            8.9.3. Regulatory framework
                            8.9.4. Reimbursement scenario
                            8.9.5. Denmark market estimates and forecasts, 2021 - 2033
                    8.10. Australia
                            8.10.1. Key country dynamics
                            8.10.2. Competitive scenario
                            8.10.3. Regulatory framework
                            8.10.4. Reimbursement scenario
                            8.10.5. Australia market estimates and forecasts, 2021 - 2033
                    8.11. Rest of the World (France, Japan, Lebanon, Israel)
                            8.11.1. Key country dynamics
                            8.11.2. Competitive scenario
                            8.11.3. Regulatory framework
                            8.11.4. Reimbursement scenario
                            8.11.5. Rest of the World (France, Japan, Lebanon, Israel) market estimates and forecasts, 2021 - 2033

Chapter 9. Competitive Landscape
                    9.1. Recent Developments & Impact Analysis, By Key Market Participants
                    9.2. Company/Competition Categorization
                            9.2.1. Innovators
                    9.3. Vendor Landscape
                            9.3.1. List of key distributors and channel partners
                            9.3.2. Key customers
                            9.3.3. Global Key company market share analysis, 2024
                            9.3.4. Boston Scientific Corporation (Nalu Medical)
                                    9.3.4.1. Company overview
                                    9.3.4.2. Financial performance
                                    9.3.4.3. Product Type benchmarking
                                    9.3.4.4. Strategic initiatives
                            9.3.5. Medtronic plc (SPR Therapeutics)
                                    9.3.5.1. Company overview
                                    9.3.5.2. Financial performance
                                    9.3.5.3. Product Type benchmarking
                                    9.3.5.4. Strategic initiatives
                            9.3.6. Curonix LLC (Stimwave Technologies)
                                    9.3.6.1. Company overview
                                    9.3.6.2. Financial performance
                                    9.3.6.3. Product Type benchmarking
                                    9.3.6.4. Strategic initiatives
                            9.3.7. Neuspera Medical, Inc
                                    9.3.7.1. Company overview
                                    9.3.7.2. Financial performance
                                    9.3.7.3. Product Type benchmarking
                                    9.3.7.4. Strategic initiatives
                            9.3.8. Bioventus Inc. (StimRouter)
                                    9.3.8.1. Company overview
                                    9.3.8.2. Financial performance
                                    9.3.8.3. Product Type benchmarking
                                    9.3.8.4. Strategic initiatives
                            9.3.9. NEURIMPULSE s.r.l.
                                    9.3.9.1. Company overview
                                    9.3.9.2. Financial performance
                                    9.3.9.3. Product Type benchmarking
                                    9.3.9.4. Strategic initiatives
                            9.3.10. Nervonik
                                    9.3.10.1. Company overview
                                    9.3.10.2. Financial performance
                                    9.3.10.3. Product Type benchmarking
                                    9.3.10.4. Strategic initiatives
                            9.3.11. Neuros Medical
                                    9.3.11.1. Company overview
                                    9.3.11.2. Financial performance
                                    9.3.11.3. Product Type benchmarking
                                    9.3.11.4. Strategic initiatives
                            9.3.12. Mainstay Medical
                                    9.3.12.1. Company overview
                                    9.3.12.2. Financial performance
                                    9.3.12.3. Product Type benchmarking
                                    9.3.12.4. Strategic initiatives
                    9.4. Heat Map Analysis/ Company Market Position Analysis
                    9.5. Estimated Company Market Share Analysis, 2024
                    9.6. List of Other Key Market Players

List of Tables

Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Peripheral Nerve Stimulators Market, by type, USD Million, 2021 - 2033
Table 4. Peripheral Nerve Stimulators Market, by indication, USD Million, 2021 - 2033
Table 5. Peripheral Nerve Stimulators Market, by mechanism, USD Million, 2021 - 2033
Table 6. Peripheral Nerve Stimulators Market, by end user, USD Million, 2021 - 2033
Table 7. U.S. peripheral nerve stimulators market, by type, USD Million, 2021 - 2033
Table 8. U.S. peripheral nerve stimulators market, by indication, USD Million, 2021 - 2033
Table 9. U.S. peripheral nerve stimulators market, by mechanism, USD Million, 2021 - 2033
Table 10. U.S. peripheral nerve stimulators market, by end user, USD Million, 2021 - 2033
Table 11. Canada peripheral nerve stimulators market, by type, USD Million, 2021 - 2033
Table 12. Canada peripheral nerve stimulators market, by indication, USD Million, 2021 - 2033
Table 13. Canada peripheral nerve stimulators market, by mechanism, USD Million, 2021 - 2033
Table 14. Canada peripheral nerve stimulators market, by end user, USD Million, 2021 - 2033
Table 15. Germany peripheral nerve stimulators market, by type, USD Million, 2021 - 2033
Table 16. Germany peripheral nerve stimulators market, by indication, USD Million, 2021 - 2033
Table 17. Germany peripheral nerve stimulators market, by mechanism, USD Million, 2021 - 2033
Table 18. Germany peripheral nerve stimulators market, by end user, USD Million, 2021 - 2033
Table 19. Australia peripheral nerve stimulators market, by type, USD Million, 2021 - 2033
Table 20. Australia peripheral nerve stimulators market, by indication, USD Million, 2021 - 2033
Table 21. Australia peripheral nerve stimulators market, by mechanism, USD Million, 2021 - 2033
Table 22. Australia peripheral nerve stimulators market, by end user, USD Million, 2021 - 2033
Table 23. UK peripheral nerve stimulators market, by type, USD Million, 2021 - 2033
Table 24. UK peripheral nerve stimulators market, by indication, USD Million, 2021 - 2033
Table 25. UK peripheral nerve stimulators market, by mechanism, USD Million, 2021 - 2033
Table 26. UK peripheral nerve stimulators market, by end user, USD Million, 2021 - 2033
Table 27. Italy peripheral nerve stimulators market, by type, USD Million, 2021 - 2033
Table 28. Italy peripheral nerve stimulators market, by indication, USD Million, 2021 - 2033
Table 29. Italy peripheral nerve stimulators market, by mechanism, USD Million, 2021 - 2033
Table 30. Italy peripheral nerve stimulators market, by end user, USD Million, 2021 - 2033
Table 31. Spain peripheral nerve stimulators market, by type, USD Million, 2021 - 2033
Table 32. Spain peripheral nerve stimulators market, by indication, USD Million, 2021 - 2033
Table 33. Spain peripheral nerve stimulators market, by mechanism, USD Million, 2021 - 2033
Table 34. Spain peripheral nerve stimulators market, by end user, USD Million, 2021 - 2033
Table 35. Denmark peripheral nerve stimulators market, by type, USD Million, 2021 - 2033
Table 36. Denmark peripheral nerve stimulators market, by indication, USD Million, 2021 - 2033
Table 37. Denmark peripheral nerve stimulators market, by mechanism, USD Million, 2021 - 2033
Table 38. Denmark peripheral nerve stimulators market, by end user, USD Million, 2021 - 2033
Table 39. Rest of the World (France, Japan, Lebanon, Israel) peripheral nerve stimulators market, by type, USD Million, 2021 - 2033
Table 40. Rest of the World (France, Japan, Lebanon, Israel) peripheral nerve stimulators market, by indication, USD Million, 2021 - 2033
Table 41. Rest of the World (France, Japan, Lebanon, Israel) peripheral nerve stimulators market, by mechanism, USD Million, 2021 - 2033
Table 42. Rest of the World (France, Japan, Lebanon, Israel) peripheral nerve stimulators market, by end user, USD Million, 2021 - 2033

List of Figures

Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Peripheral Nerve Stimulators Market, Market Segmentation
Fig. 7 Market Driver Analysis (Current & Future Impact)
Fig. 8 Market Restraint Analysis (Current & Future Impact)
Fig. 9 Market Opportunity Analysis (Current & Future Impact)
Fig. 10 Market Challenge Analysis (Current & Future Impact)
Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
Fig. 12 Porter’s Five Forces Analysis
Fig. 13 Country Marketplace: Key Takeaways
Fig. 14 Peripheral Nerve Stimulators Market, by Type, 2021 - 2033 (USD Million)
Fig. 15 Peripheral Nerve Stimulators Market, for Temporary Percutaneous Systems, 2021 - 2033 (USD Million)
Fig. 16 Peripheral Nerve Stimulators Market, for Wireless Micro-Implantable Systems, 2021 - 2033 (USD Million)
Fig. 17 Peripheral Nerve Stimulators Market, for Traditional IPG Systems, 2021 - 2033 (USD Million)
Fig. 18 Peripheral Nerve Stimulators Market, by Indication, 2021 - 2033 (USD Million)
Fig. 19 Peripheral Nerve Stimulators Market, for Restorative Multifidus Stimulation, 2021 - 2033 (USD Million)
Fig. 20 Peripheral Nerve Stimulators Market, for Peripheral Neuropathic & Post-Surgical/Traumatic Pain, 2021 - 2033 (USD Million)
Fig. 21 Peripheral Nerve Stimulators Market, by Mechanism, 2021 - 2033 (USD Million)
Fig. 22 Peripheral Nerve Stimulators Market, for External Direct Power, 2021 - 2033 (USD Million)
Fig. 23 Peripheral Nerve Stimulators Market, for Transcutaneous Wireless Power, 2021 - 2033 (USD Million)
Fig. 24 Peripheral Nerve Stimulators Market, for Internal Battery Power, 2021 - 2033 (USD Million)
Fig. 25 Peripheral Nerve Stimulators Market, by End User, 2021 - 2033 (USD Million)
Fig. 26 Peripheral Nerve Stimulators Market, for Hospital Outpatient Departments, 2021 - 2033 (USD Million)
Fig. 27 Peripheral Nerve Stimulators Market, for Ambulatory Surgical Centers, 2021 - 2033 (USD Million)
Fig. 28 Peripheral Nerve Stimulators Market, for Outpatient Interventional Pain Clinics / OBLs, 2021 - 2033 (USD Million)
Fig. 29 Country Outlook, 2024 & 2033
Fig. 30 U.S. Peripheral Nerve Stimulators Market, 2021 - 2033 (USD Million)
Fig. 31 Canada Peripheral Nerve Stimulators Market, 2021 - 2033 (USD Million)
Fig. 32 Germany Peripheral Nerve Stimulators Market, 2021 - 2033 (USD Million)
Fig. 33 Australia Peripheral Nerve Stimulators Market, 2021 - 2033 (USD Million)
Fig. 34 UK Peripheral Nerve Stimulators Market, 2021 - 2033 (USD Million)
Fig. 35 Italy Peripheral Nerve Stimulators Market, 2021 - 2033 (USD Million)
Fig. 36 Spain Peripheral Nerve Stimulators Market, 2021 - 2033 (USD Million)
Fig. 37 Denmark Peripheral Nerve Stimulators Market, 2021 - 2033 (USD Million)
Fig. 38 Rest of the World (France, Japan, Lebanon, Israel) Peripheral Nerve Stimulators Market, 2021 - 2033 (USD Million)